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Summary
Blood and endothelium arise in close association during
development, possibly from a common precursor, the
hemangioblast [1–4]. Genes essential for blood and endothe-
lial development contain functional ETS binding sites, and
binding and expression data implicate the transcription fac-
tor, friend leukaemia integration 1 (Fli1) [5–10]. However,
loss-of-function phenotypes in mice, although suffering
both blood and endothelial defects, have thus far precluded
the conclusion that Fli1 is essential for these two lineages
[11, 12]. By using Xenopus and zebrafish embryos, we
show that loss of Fli1 function results in a substantial reduc-
tion or absence of hemangioblasts, revealing an absolute re-
quirement. TUNEL assays show that the cells are eventually
lost by apoptosis, but only after the regulatory circuit has
been disrupted by loss of Fli1. In addition, a constitutively
active form of Fli1 is sufficient to induce expression of key
hemangioblast genes, such as Scl/Tal1, Lmo2, Gata2, Etsrp,
and Flk1. Epistasis assays show that Fli1 expression is in-
duced byBmp signaling orCloche, depending on the heman-
gioblast population, and in both cases Fli1 acts upstream of
Gata2, Scl, Lmo2, and Etsrp. Taken together, these results
place Fli1 at the top of the transcriptional regulatory hierar-
chy for hemangioblast specification in vertebrate embryos.
Results
Fli1 Is Required for Both Primitive and Definitive
Hemangioblast Formation
In the early Xenopus embryo, we have described two popula-
tions of hemangioblasts that represent the precursors of the
primitive and definitive blood and endothelial lineages [10].
The primitive hemangioblast population is located in the ante-
rior of the neurula stage embryo (w16 hpf), just below the
cement gland, whereas the definitive population is found in
the dorsal lateral plate (DLP) of the tailbud stage embryo ap-
proximately 12 hr later. Fli1 is one of the earliest markers to
be expressed in both populations [10].
To knock down Fli1 expression in Xenopus embryos, we
made use of an antisense morpholino (MO) designed against
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was established by monitoring the downregulation of Scl
expression in the anterior hemangioblast (Figure S1 available
online). When targeted to the dorsal marginal zone (DMZ) at
the 4/8 cell stage (the region giving rise to the primitive heman-
gioblast population [10]), the expression of many genes later
expressed in erythroid, myeloid, or endothelial cells was
downregulated (Figures 1A–1L, 1S, 1T, 1V, and 1W, arrows).
Thus, expression of Scl, Lmo2, Fli1, Flk1, Mpo, SpiB, and
Runx1 were all severely reduced in Fli1 MO-injected embryos
(morphants) monitored at stage 17. This effect was specific
to the hemangioblasts: neither Runx1 expression in Rohon
Beard cells of the neural plate nor Lmo2 expression in the so-
mites was affected (Figures S4A–S4D). The effect onGata2 ex-
pression, when Fli1 MO was injected, was monitored by in situ
hybridization on sections, because Gata2 is expressed in all
three germ layers at neurula stages [13]. Gata2 expression in
the Fli1 morphants was reduced, albeit modestly, in the meso-
derm of the anterior hemangioblast region (Figures 1I and 1L,
arrows). The effect on Scl expression has been reported previ-
ously with the same MO [14], but here we show that all the
hemangioblast genes tested were downregulated, consistent
with a primary role for Fli1 at the top of the genetic hierarchy
leading to formation of the embryonic hemangioblast.
Because the effect of the Fli1 MO on Gata2 expression in the
anterior hemangioblast was a subtle one, we turned to Gata2
morphants to establish the hierarchy between Gata2 and Fli1.
A combination of MOs directed against the ATG regions of
Gata2A and B, the two pseudo-alleles of Xenopus laevis,
have previously been shown to block globin expression [15],
and we titrated the MOs monitoring this activity to optimize
the dose (Figure S2). When we injected these Gata2 MOs into
the DMZ at the 4-cell stage (the region containing the precur-
sors of the anterior hemangioblast population), Scl and Lmo2
expression at stage 16/17 was significantly reduced whereas
Fli1 expression remained unchanged (Figures 1M–1R). This,
together with the reduction, albeit only slight, ofGata2 expres-
sion in Fli1 morphants, suggests that Fli1 may be above Gata2
in the regulatory hierarchy determining the development of the
primitive hemangioblast population. The small effects of the
Fli1 and Gata2 MOs on each other’s expression compared to
their effects on Scl and Lmo2 expression are consistent with
both Fli1 and Gata2 being upstream of Scl and Lmo2.
To further test the hierarchical relationship of Fli1 with Scl,
Lmo2, and Gata2, we tried to rescue the Fli1 morphant pheno-
type by coinjection of mRNAs for Scl, Lmo2, and Gata2. As
shown in Figures 1S–1X, the reduction of expression of SpiB
and Runx1 was partially rescued by coinjection of the three
mRNAs, in a dose-dependent manner (data not shown), con-
sistent with Fli1 acting upstream of Scl, Lmo2, and Gata2 in
the anterior hemangioblast population.
In order to look at the adult hemangioblast, we targeted the
Fli1 MO to the ventral marginal zone (VMZ) at the 4/8 cell stage
(the region giving rise to the DLP) [16]. We found that blood and
endothelial gene expression in the adult DLP hemangioblast at
tailbud stages was eliminated (Figures 2A–2L, black arrows).
The expression of Scl, Gata2, Lmo2, Flk1, Msr, and Tie2
(data not shown) were all downregulated. Fli1 expression in
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(A–L) Fli1 requirement for the primitive hemangioblast. Xenopus embryos injected with Fli1 MO in the DMZ at the 4-cell stage were processed for in situ
hybridization at stage 17, either as whole mounts (WISH) (A–H, J, K) or as sections (I, L).
(M–X) Gata2 morphants and rescue experiments confirm that Fli1 is at the top of the primitive hemangioblast hierarchy. Gata2 MOs were injected into the
DMZ at the 4-cell stage and embryos were processd for WISH at stages 16/17. Expression ofSpiB (S–U) andRunx1 (V–X) was partially rescued by coinjection
of mRNA for Scl, Lmo2, and Gata2.
Arrows mark the primitive hemangioblast population. Proportion of embryos with phenotype shown indicated in top right corner.the hemangioblast component of the DLP was also abolished
(Figures 2A and 2B, cells outlined by red dotted line in Fig-
ure 2A). The remaining Fli1 expression in the DLP region in
Fli1 morphants (Figure 2B, black dotted line) is in the proneph-
ric duct (PND) precursors [10]. The reduced effect on the PND
was confirmed with additional markers, Pax2 and Pax8, and
expression of all these markers plus Runx1 and aT4Globin in
the pVBI (also derived from the VMZ) was also decreased by
this injection (Figures 2C–2L; Figure S3, red arrows). Overall,
these results show that Fli1 is required for primitive and defin-
itive hemangioblast formation in Xenopus embryos.
To confirm the hierarchy of transcription factors involved in
establishing the definitive hemangioblast program in the DLP,
we targeted theGata2 MOs to the VMZ and monitored expres-
sion of Fli1, Scl, Lmo2, and Msr in the DLP soon after expres-
sion of these genes is first detectable. Whereas expression of
Scl, Lmo2, and Msr was strongly downregulated in the Gata2
morphants (Figures 2O–2T, arrows), the expression of Fli1 re-
mained unaffected (Figures 2M and 2N, arrows). These results
suggest that Fli1 is at the top of the transcriptional hierarchy
programming the definitive hemangioblast.
Incorrectly Programmed Hemangioblasts
in Fli1 Morphants Undergo Apoptosis
We next asked whether the loss of expression of blood and
endothelial markers in both embryonic and definitivehemangioblast populations was the result of respecification
or loss of the cells. We monitored expression of MyoD,
Nkx2.5, Blimp1, and BMP4, genes that are expressed in re-
gions abutting the embryonic hemangioblast population, and
found them unchanged in Fli1 morphants (Figures S4E–S4L),
suggesting that respecification is not the cause of loss of he-
mangioblast gene expression. In contrast, TUNEL assays on
Fli1 morphants at stage 17 (embryonic hemangioblasts) and
stage 26 (adult hemangioblasts) revealed apoptosis in regions
of the embryo where Scl expression was lost (Figures S5C,
S5D, S5I, and S5J). Broader apoptosis in the DLP area at stage
26 may correspond to the partial loss of the PND (Figures S3E–
S3H). Looking at times when Scl is first expressed (stage 14 for
embryonic and stage 24 for adult hemangioblasts), we found
loss of Scl expression in Fli1 morphants in the absence of ap-
optosis (Figures S5A, S5B, S5E, and S5H). Similar results were
obtained for Fli1 expression (data not shown). These results
suggest that loss of the hemangioblast program leads to
apoptosis rather than being a consequence of it.
Activated Fli1 Transactivates Early Hemangioblast
Genes through Scl, Etsrp, and Cloche
Our experiments so far in Xenopus have established the hier-
archical relationship between the transcription factors Fli1,
Gata2, Scl, and Lmo2. We were interested to investigate this
relationship in zebrafish and also to define the position of
Current Biology Vol 18 No 16
1236Figure 2. Fli1 Is Required Upstream of Gata2 for the Definitive Hemangioblast Program
(A–L) Fli1 requirement for the definitive hemangioblast. Xenopus embryos injected with Fli1 MO in the VMZ at the 4-cell stage were processed for WISH at
stage 26. Note remaining DLP signal in (B) marks the pronephric duct (PND). Red outlines hemangioblasts, black outlines PND. Black arrows, DLP; red ar-
rows, pVBI.
(M–T) Gata2 morphants confirm that Fli1 is at the top of the definitive hemangioblast hierarchy. Embryos injected with Gata2 MOs in the VMZ at the 4-cell
stage were processed for WISH for expression in the DLP (arrows) at stages shown.Fli1 in relation to the important regulators of blood and endo-
thelium, Cloche and Etsrp, that are specific to the zebrafish.
We began by looking at loss-of-function embryos with an
MO against the 50 untranslated region (UTR) immediately up-
stream of the Fli1 translation initiation codon. Although we
were able to demonstrate activity of the MO by knocking
down GFP expression from a transgene (data not shown),
embryos injected with the MO were phenotypically normal
and expression of blood and endothelial markers was un-
changed (data not shown), raising the possibility of ETS factor
redundancy [17]. Zebrafish have more ETS factors than other
vertebrates (31 versus 24–29 for frog, mouse, and human),
and, in particular, the Fli1 locus has been duplicated giving
rise to the Fli1b gene [18]. We and others have used combina-
tions of MOs but thus far have been unable to significantly
disrupt both blood and endothelium (data not shown) [19, 20].
We therefore turned to gain-of-function experiments. To
functionally test the ability of Fli1 to transactivate early heman-
gioblast genes, we injected full-length Fli1 RNA into zebrafish
embryos but it had little effect on Scl, Lmo2, Gata2, or Flk1 ex-
pression (Figure 3, compare [B], [E], [H], [N] with [A], [D], [G],
[M]). The lack of effect is possibly because, like other ETS fac-
tors, Fli1 needs activating signals [21], or alternatively partners[5]. We therefore also tested a constitutively active form of Fli1,
in which the transactivation domain of the viral VP16 protein
was fused to full-length Fli1 coding sequences. Fli1-VP16
RNA injection caused strong ectopic expression of Scl,
Lmo2, Gata2, Flk1, and Etsrp as well as of Fli1 itself (Figure 3,
compare arrowed regions in [C], [F], [I], [L], [O], [T] with [A], [D],
[G], [J], [M], [S]). In contrast, there was no expansion of expres-
sion of the blood markerGata1 (Figure 3, compare [R] with [P]).
We therefore conclude that activated Fli1 protein can transac-
tivate early hemangioblast genes but that the ectopic heman-
gioblast-like cells are unable to differentiate into red blood
cells expressing Gata1. This might reflect an absence of the
necessary blood differentiation signals in these ectopic re-
gions of the embryo. Nevertheless, together with the observa-
tions that Fli1 expression is initially unaffected in Cloche
embryos (Figures S6A and S6B) [9], or by the loss of Scl or
Lmo2 [22, 23], these data are consistent with Fli1 acting near
the top of the hemangioblast genetic hierarchy.
To further establish the hierarchy between these key regula-
tors, we coinjected embryos with Fli1-VP16 RNA and either Scl
orEtsrpMOs. As already discussed, injection ofFli1-VP16 RNA
alone leads to increased expression ofFlk1 (Figures 3O and 4B,
arrows), whereas injection of Scl MO alone significantly
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previous data from us and others [23, 24]. Injection ofFli1-VP16
RNA together with Scl MO failed to rescue the loss of Flk1
expression because of depletion of Scl protein, with the coin-
jected embryos showing the same phenotype as Scl MO injec-
tion alone (Figure 4D), suggesting thatScl is downstream ofFli1
in hemangioblast formation. Similarly, injection of Etsrp MO
greatly reduced endothelial cell numbers as reported previ-
ously (Figure 4E) [18]. In the coinjected embryos, Fli1-VP16
RNA failed to rescue the Etsrp MO phenotype (Figure 4F), indi-
cating that Etsrp is also downstream of Fli1. Thus, Fli1 transac-
tivates at least one of its targets through Scl and Etsrp.
The Cloche gene has not yet been identified [25] and there-
fore we cannot determine whether Cloche expression is upre-
gulated by Fli1-VP16. However, we can determine whether
Fli1 activity is dependent on Cloche. We therefore injected
Fli1-VP16 RNA into Clo2/2 embryos to determine whether
hemangioblast gene expression could be rescued. When Scl
expression was monitored at 10 somites, no rescue was
seen, even though the Fli1-VP16 RNA was able to induce ec-
topic expression in wild-type embryos (Figures 4G–4J, arrows).
Thus, the activity of Fli1-VP16 we see in wild-type embryos
must be dependent on Cloche. We therefore conclude that
Fli1 is upstream or parallel to Cloche in the hemangioblast
Figure 3. Upregulation of Blood and Endothelial
Markers by Fli1-VP16
WISH of zebrafish 10 s stage embryos injected
with Fli1 or Fli1-VP16. In whole-mounted em-
bryos, head to top, focusing on PLM (G–M). In
flat-mounted embryos, head to top (A–F, M–R)
or to left (S, T). Red arrows indicate expanded
expression.
program. Taken together, these zebra-
fish data are consistent with Fli1 acting
at the top of the hemangioblast genetic
hierarchy through, or together with, other
key regulators, such as Scl, Etsrp, and
Cloche.
Differential Control by Bone
Morphogenetic Proteins of Fli1
Expression in Adult and Embryonic
Hemangioblasts
Inhibition of bone morphogenetic pro-
tein (Bmp) signaling in Xenopus em-
bryos impairs the programming of both
adult and embryonic hemangioblasts
[10]. In the specific case of Fli1, though,
although expression in the adult heman-
gioblast is dependent on Bmp signaling,
it appears to be independent of it in the
embryonic hemangioblast [10]. Bmp
signaling is also required for hemangio-
blast induction in zebrafish but the re-
sponse of Fli1 has not been recorded
[26]. To determine the situation in zebra-
fish, we made use of a heat-shock-in-
ducible dominant-negative Bmp recep-
tor transgenic line [26]. When we heat
shocked this line at 30% epiboly (i.e.,
before gastrulation), the expression of
Fli1 as well as the other hemangioblast
markers, Scl and Gata2, in the posterior lateral mesoderm
(PLM) was substantially reduced (Figures S7A–S7F). We also
checked Fli1 expression in the dino mutant, a well-character-
ized mutant resulting in enhanced Bmp signaling. Consis-
tently, the expression of Fli1, together with Gata2 and Scl,
was upregulated in the vicinity of the PLM (Figure S7G, arrows
and data not shown). Cardiac precursor (Nkx2.5) and hindbrain
(Krox20) marker expression acted as controls (Figure S7H).
The PLM in zebrafish gives rise to adult blood and endothe-
lial cells and is therefore homologous to the DLP in frogs, in
which Fli1 expression is also regulated by Bmp signaling
[10]. Furthermore, because the PLM in fish also gives rise to
embryonic erythroid but not myeloid cells, it could be viewed
as homologous to the posterior VBI precursors in Xenopus
rather than the anterior hemangioblast [27]. Therefore, in order
to determine if the zebrafish population homologous to the
anterior hemangioblast in Xenopus behaves similarly with
respect to the Fli1 response to Bmp signaling, we monitored
gene expression in the anterior lateral mesoderm (ALM) in
heat-shocked embryos. We found that relatively normal num-
bers of Fli1-expressing cells were present at 6 somites (Fig-
ures S7I and S7J). We therefore conclude that the anterior
hemangioblast populations in Xenopus and zebrafish that
give rise to embryonic blood and endothelium express Fli1 in
Current Biology Vol 18 No 16
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(A–J) WISH on wild-type or Cloche mutant zebrafish embryos injected with combinations of Fli1-VP16 mRNA and/or Scl/Etsrp MOs. 10 s stage, dorsal view,
head to top.
(K) A genetic regulatory network linking Bmp to Fli1 at the top of the hemangioblast hierarchy, drawn according to Davidson et al. [29]. Solid lines, direct
regulation; dashed lines, no evidence for direct or indirect. Evidence for links quoted in text, apart from Gata2 as a direct Bmp target [32].a Bmp-independent manner in contrast to the posterior
hemangioblasts that give rise to adult blood.
Discussion
Most of the genes known to be essential for the early blood and
endothelial programmes contain ETS binding sites [5, 28]. Sev-
eral members of the ETS family are present in the precursors to
blood and endothelium in the embryo, and of these, Fli1 has
emerged as a strong candidate based on its occupancy of
these sites in putative hemangioblast-containing populations
of cells [7]. However, the null phenotype in mice has been
ambiguous [11, 12]. To clarify the early role of Fli1 in blood
and endothelial development, we took advantage of two or-
ganisms that have been studied extensively for the early devel-
opment of these cells. In particular, the locations and gene-expression profiles of the cell populations giving rise to these
two tissues are well documented. We find that, in the absence
of Fli1, neither population is programmed to the hemangio-
blast fate and that eventually the cells are lost by apoptosis,
confirming Fli1 as a master regulator of blood and endothelial
development.
In the building of genetic regulatory networks (GRNs), Da-
vidson and his colleagues have suggested that three criteria
need to be fulfilled to demonstrate regulatory connections
between transcription factors [29]. First, the proposed target
needs to respond appropriately when the proposed regula-
tor’s expression or activity is perturbed; second, the expres-
sion profiles of the genes need to fit the proposed relationship;
and finally, there needs to be evidence that the regulator binds
to its target. Pimanda et al. have drawn a core GRN, or kernel,
for the hemangioblast, based on criteria 2 and 3 [7]. Here we
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proposed activities of Fli1 and to a lesser extent Gata2, i.e.,
criterion 1. We show that Fli1 fulfills all three criteria as a posi-
tive regulator of Gata2, Scl, Lmo2, and itself. Our data also
show that Gata2 fulfills all three criteria for Scl and Lmo2, but
we find no evidence that it regulates Fli1, in contrast to the
network of Pimanda et al. [7]. These conclusions have been
built into a new hemangioblast kernel (Figure 4K). Such a
core regulatory network may be conserved even beyond verte-
brates because overexpression of the Drosophila pointed
gene (the ortholog of the ETS family of proteins in vertebrates)
drastically increased the number of circulating hemocytes in
larvae [30].
Perturbations of Scl and Lmo2 are consistent with the pro-
posed locations of Fli1 and Gata2 in the hierarchy [22, 23].
Thus, loss of either has no effect on Fli1 or Gata2 expression,
again in contrast to the network of Pimanda et al. [7]. Further-
more, Scl is required for Fli1-VP16 to drive Flk1 expression
(Figures 4A–4D), and loss of downstream Runx1 and SpiB ex-
pression in Fli1 morphants is rescued by a combination of Scl,
Lmo2, and Gata2 mRNAs (Figures 1S–1X). With respect to
regulation of Fli1 expression, we show that Cloche is required
in the anterior hemangioblast (Figure S6), whereas Bmp is
required in the posterior hemangioblast (Figure S7; see also
[10]). Furthermore, although Bmp is not required to drive Fli1
expression in the anterior hemangioblast, both Bmp and Fli1
are required to drive Scl. In principle this could have indicated
that Fli1 is upstream of Bmp. However, at least for Bmp4, the
dominant Bmp in early Xenopus embryos, this does not
seem to be the case (Figures S4K and S4L). Thus, a feasible
scenario in the anterior hemangioblast is that Bmp drives
Gata2 and Gata2 plus Fli1 drive Scl via the demonstrated
ETS-Gata sites (Figure 4K) [5].
Careful temporal monitoring of hemangioblast marker ex-
pression and the onset of cell death in Fli1 morphants demon-
strated that disruption of the hemangioblast program occurred
before the cells underwent apoptosis. Thus, Fli1 is required for
the induction of the hemangioblast program and also for cell
survival, but whether Fli1 is acting directly on the cell-death
pathway cannot be determined from the available data. It is
noteworthy, though, that Fli1 has already been shown to dis-
play antiapoptotic activity in several cell types including avian
erythroblasts, mouse fibroblasts, and lymphoid cells, possibly
through the upregulation of Bcl2, an antiapoptotic protein [31].
So it is possible that the observed cell death is directly caused
by the loss of Fli1 rather than being a consequence of the
misprogramming of the cells.
In conclusion, the data presented here finally confirm a po-
sition for Fli1 at the top of the genetic cascade establishing
the blood and endothelial programmes within cells of the
mesoderm in the early embryo. We find some differences
between the different populations with respect to the regula-
tion of Fli1 itself, but in each case we find that Fli1 function is
indispensable.
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